DNA test could reveal Who's at risk from Life-Threatening diabetes drug complication
NCT ID NCT05402579
Summary
This study aimed to find out if a person's genetic makeup can help predict their risk of developing a dangerous condition called diabetic ketoacidosis (DKA) while taking SGLT2 inhibitor drugs for type 2 diabetes. Researchers studied 63 adults who were hospitalized, comparing the genes of those who experienced DKA to those who did not. The goal is to use this genetic information to help doctors better decide which patients can safely use these beneficial medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Joseph's Health Centre (Unity Health Toronto)
Toronto, Ontario, Canada
-
Toronto General Hospital (University Health Network)
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.